L309-0126 Screening compound: N-(2-methoxyethyl)-4-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide

L309-0126 Screening compound: N-(2-methoxyethyl)-4-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
L309-0126 Screening compound: N-(2-methoxyethyl)-4-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L309-0126
N-(2-methoxyethyl)-4-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L309-0126

Molecular Formula

C15H18N4O6S (C15 H18 N4 O6 S)

Compound Name

N-(2-methoxyethyl)-4-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide

IUPAC name

N-(2-methoxyethyl)-4-[(5-methyl-124-oxadiazol-3-yl)methyl]-3-oxo-34-dihydro-2H-14-benzoxazine-6-sulfonamide

SMILES

Cc1nc(CN2c(cc(cc3)S(NCCOC)(=O)=O)c3OCC2=O)no1

InChI

InChI=1S/C15H18N4O6S/c1-10-17-14(18-25-10)8-19-12-7-11(26(21,22)16-5-6-23-2)3-4-13(12)24-9-15(19)20/h3-4,7,16H,5-6,8-9H2,1-2H3

InChI Key

VTIQHYMGHHLKHI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27243966

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

382.4

Hydrogen Bond Acceptors Count

12.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

0.383

Distribution Coefficient, logD

0.383

Water Solubility, LogSw

-2.45

Polar Surface Area

106.449

Acid Dissociation Constant (pKa)

11.57

Base Dissociation Constant (pKb)

-4.18

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.00

L309-0126 in Drug Discovery

Included in Screening Libraries

CNS MPO Library (28609 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with L309-0126 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L309-0126?
Check Price and Availability of L309-0126, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L309-0126 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L309-0126
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L309-0126
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L309-0126 available by request